Molecular epidemiology of clinical isolation of carbapenem-resistant Enterobacterales and application of carbapenemase inhibitor enhancement test.
10.11817/j.issn.1672-7347.2023.230229
- Author:
Hongling LI
1
;
Yiming ZHONG
2
;
Qun YAN
2
;
Wen'en LIU
2
;
Xianghui LIANG
3
Author Information
1. Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, China. xylihongling@163.com.
2. Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, China.
3. Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, China. liangxh901@csu.edu.cn.
- Publication Type:Journal Article
- Keywords:
carbapenem-resistant Enterobacterales;
carbapenemase;
carbapenemase inhibition enhancement test;
carbapenemase producing Enterobacterales
- MeSH:
Humans;
Carbapenems/pharmacology*;
Molecular Epidemiology;
Bacterial Proteins/analysis*;
beta-Lactamases/analysis*;
Klebsiella pneumoniae/genetics*;
Escherichia coli;
Microbial Sensitivity Tests;
Serine;
Anti-Bacterial Agents/pharmacology*
- From:
Journal of Central South University(Medical Sciences)
2023;48(8):1210-1216
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:The prevalence of carbapenem-resistant Enterobacterales (CRE) presents a significant challenge in clinical anti-infective treatment. This study aims to investigate drug resistance and the molecular epidemiological characteristics of CRE in our area. Additionally, we seek to evaluate practicality of utilizing carbapenemase inhibitor enhancement test in clinical laboratory.
METHODS:Non-repeated CREs isolated from clinical specimens at Xiangya Hospital, Central South University, were collected. Minimum inhibitory concentration (MIC) combined with Kirby-Bauer (KB) assay was used to detect the drug susceptibility of the strains, and 13 carbapenemase-producing genes were detected by PCR. The phenotype of 126 strains of carbapenemase-producing Enterobacterales identified by PCR was detected by the carbapenemase inhibitor enhancement test to understand the agreement between the method and the gold standard PCR results.
RESULTS:Among 704 CRE strains examined, we observed significant drug resistance in 501 strains dentified as carbapenemase-producing Enterobacterales (CPE). Klebsiella pneumoniae was the predominant CPE strain, followed by Enterobacter cloacae and Escherichia coli. A total of 9 carbapenemase types were detected, including Klebsiella pneumoniae carbapenemase (KPC), New Delhi metallo-β-lactamase (NDM), Verona integron- encoded metallo-β-lactamases (VIM), imipenemase (IMP), oxacillinase-48 (OXA-48), and rare imipenem-hydrolyzing β-lactamase (IMI), adelaide imipenemase (AIM), Bicêtre carbapenemase (BIC), and guiana extended-spectrum β-lactamase (GES). The detection rate of KPC serine carbapenemase was 61.7% (309/501). The carbapenemase inhibitor enhancement test exhibited a 100% consistency rate for the strains producing Class A serine carbapenemase and/or Class B metallo-β-lactamases.
CONCLUSIONS:CRE strains in Changsha, Hunan, China, are wide distribution and exhibit carbapenemase production. The main mechanism of carbapenem resistance in these bacterias is predominatly attributed to the production of KPC serine carbapenemase. The presence of GES and IMI genes carried by Enterobacterales has been detected for the first time in this region. The carbapenemase inhibitor enhancement test has been proven to be an accurate method for detecting CRE producing Class A serine carbapenemase and/or Class B metallo-β-lactamases. This method offers simpicity of operation and ease of results interpretation, making it weel-suited meeting the clinical microbiology laboratory's reguirements for the detection of serine carbapenemase and metallo-β-lactamases.
